cronos group glp-1 receptor agonist weight management diabetes treatments The Landscape Of Agonists In And Obesity Treatment How GLP-1 Receptor Agonists Evolved

95% CI 0.89, 0.96) and all-cause mortality rate (HR 0.70

In a trial, people lost 75% fat and 25% muscle.

Gastric inhibitory polypeptide (GIP) and glucagonlike peptide1 (GLP1) are the two primary incretin hormones secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic cells

While prescription versions can amplify its effects, physicians say diet, movement and metabolic health still shape how well GLP-1 works naturally.

And for good reason, the science behind them is solid, and the results can be dramatic

Understand causes, benefits, and practical insights to support better health and informed decisions.